GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sunho Biologics Inc (HKSE:02898) » Definitions » PB Ratio

Sunho Biologics (HKSE:02898) PB Ratio : 1.12 (As of Mar. 26, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Sunho Biologics PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-03-26), Sunho Biologics's share price is HK$4.22. Sunho Biologics's Book Value per Share for the quarter that ended in Jun. 2024 was HK$3.77. Hence, Sunho Biologics's PB Ratio of today is 1.12.

The historical rank and industry rank for Sunho Biologics's PB Ratio or its related term are showing as below:

HKSE:02898' s PB Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 1.59
Current: 1.12

During the past 2 years, Sunho Biologics's highest PB Ratio was 1.59. The lowest was 0.00. And the median was 0.00.

HKSE:02898's PB Ratio is ranked better than
75.51% of 1282 companies
in the Biotechnology industry
Industry Median: 2.43 vs HKSE:02898: 1.12

Back to Basics: PB Ratio


Sunho Biologics PB Ratio Historical Data

The historical data trend for Sunho Biologics's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunho Biologics PB Ratio Chart

Sunho Biologics Annual Data
Trend Dec22 Dec23
PB Ratio
- -

Sunho Biologics Semi-Annual Data
Dec22 Jun23 Dec23 Jun24
PB Ratio - - - 1.87

Competitive Comparison of Sunho Biologics's PB Ratio

For the Biotechnology subindustry, Sunho Biologics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sunho Biologics's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sunho Biologics's PB Ratio distribution charts can be found below:

* The bar in red indicates where Sunho Biologics's PB Ratio falls into.


';

Sunho Biologics PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Sunho Biologics's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Jun. 2024)
=4.22/3.766
=1.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Sunho Biologics  (HKSE:02898) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Sunho Biologics PB Ratio Related Terms

Thank you for viewing the detailed overview of Sunho Biologics's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sunho Biologics Business Description

Traded in Other Exchanges
N/A
Address
No. 198 Peninsula Middle Road, Dipu Street, Room 302, Building 3, Anji County, Zhejiang Province, Huzhou, CHN
Sunho Biologics Inc is a clinical-stage biopharmaceutical company that focuses on the discovery, development and commercialization of biologics for the treatment of cancers and autoimmune diseases. It has three Core Products, IAH0968, IAP0971, and IAE0972, all of which are developed in-house. IAH0968 is an antibody-dependent cell-mediated cytotoxicity (ADCC) enhanced monoclonal antibody (mAb), and the company has initiated Phase II clinical trials for biliary tract carcinoma (BTC) and colorectal cancer (CRC). IAP0971 and IAE0972 are both immunocytokines and It has completed Phase I clinical trials for advanced solid tumors including non-small cell lung cancer (NSCLC) and CRC.
Executives
Sunho Fortune Investments Limited 2201 Interest of corporation controlled by you
Trident Trust Company (hk) Limited 2301 Trustee
Zhang Feng 2201 Interest of corporation controlled by you
Sunho Wisdom Investments Limited 2101 Beneficial owner

Sunho Biologics Headlines

No Headlines